St. Jude Medical halts the Enlightn IV trial of its renal denervation technology just a few months after getting the green light to begin enrollment.
St. Jude Medical (NYSE:STJ) is calling off the Enlightn IV trial of the next generation of its renal denervation technology, just a few months after it began.
Edwards Lifesciences shares slide more than 5% after the medical device company forecasts sales for its flagship Sapien replacement heart valve for next year that miss analysts' expectations.
A conservative forecast for 2014 sent shares of Edwards Lifesciences (NYSE:EW) down more than 5% yesterday and kept them flat today, as the medical device company said it expects more competition next year for its flagship Sapien replacement heart valve.
A jury awarded $18 million to a Washington woman whose Medtronic endotracheal tube was set on fire during surgery, finding the physicians negligent but not Medtronic's design of the device.
A jury in Washington last week awarded $18 million to Becky Anderson, whose Medtronic (NYSE:MDT) endotracheal tube was set on fire during a laser surgery procedure, finding the physicians, their practices and the hospital negligent and responsible but exempting Medtronic from any culpability.
Minneapolis medtech giant Medtronic implants the 1st human patient with its tiny, minimally invasive Micra Transcatheter Pacing System.
Medtech giant Medtronic (NYSE:MDT) this week announced 1st-in-human implantation of its tiny catheter-based pacemaker, the Micra Transcatheter Pacing System.
Medtech titan Medtronic says its Prestige cervical disc replacement system resulted in fewer follow-on surgeries and higher rates of overall patient success compared with spinal fusion.
Minnesota medtech titan Medtronic (NYSE:MDT) unveiled 7-year outcomes for patients undergoing artificial disc replacement, saying the procedure resulted in fewer revision surgeries than spinal fusion.
Medtech titan Medtronic wins European and Australian regulatory approval for next-generation components of its Symplicity renal denervation treatment for drug-resistant hypertension.
Neurosurgeon Dr. Philip Starr tells MassDevice.com about Medtronic's new Activa PC+S brain monitoring, recording and stimulating implant and its potential for treating neurological and psychiatric disease.
Deep-brain stimulation is about to get a major upgrade and medtech titan Medtronic (NYSE:MDT) is on the frontier, according to neurosurgeon Dr. Philip Starr.